RARRES2’s impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis
Main Author: | Quazi T. H. Shubhra |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Military Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40779-023-00480-w |
Similar Items
-
RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer
by: Yi-Qun Li, et al.
Published: (2023-07-01) -
Prostate Cancer—Focus on Cholesterol
by: Lucija Škara, et al.
Published: (2021-09-01) -
RARRES1 inhibits hepatocellular carcinoma progression and increases its sensitivity to lenvatinib through interaction with SPINK2
by: Yarong Guo, et al.
Published: (2024-02-01) -
Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC
by: Andreas Kroh, et al.
Published: (2023-12-01) -
Caffeic acid phenethyl ester reverses doxorubicin resistance in breast cancer cells via lipid metabolism regulation at least partly by suppressing the Akt/mTOR/SREBP1 pathway
by: Lu‐Chang Liang, et al.
Published: (2023-06-01)